CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Ordinary Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balances at Dec. 31, 2022	$ 1	$ 1,295,725	$ (15)	$ (853,911)	$ 441,800
Balance (in shares) at Dec. 31, 2022	65,227
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs	$ (1)	(197,051)			(197,052)
Repurchase of ordinary shares, net of transaction costs (in shares)	(18,634)
Proceeds from ESPP purchases		619			619
Proceeds from ESPP purchases (in shares)	86
Employee share-based compensation expense		25,371			25,371
Issuance of restricted shares (in shares)	1,651
Repurchase of shares to satisfy tax withholding		(2,500)			(2,500)
Repurchase of shares to satisfy tax withholding (in shares)	(239)
Net unrealized gain (loss) on marketable securities			(50)		(50)
Net loss				(55,193)	(55,193)
Balances at Dec. 31, 2023		1,122,164	(65)	(909,104)	$ 212,995
Balance (in shares) at Dec. 31, 2023	48,091				48,091
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(445)			$ (445)
Repurchase of ordinary shares, net of transaction costs (in shares)	(38)
Proceeds from the sale of ordinary shares		99			99
Proceeds from the sale of ordinary shares (in shares)	11
Proceeds from ESPP purchases		508			508
Proceeds from ESPP purchases (in shares)	61
Employee share-based compensation expense		21,393			21,393
Issuance of restricted shares (in shares)	1,641
Repurchase of shares to satisfy tax withholding		(2,659)			(2,659)
Repurchase of shares to satisfy tax withholding (in shares)	(295)
Net unrealized gain (loss) on marketable securities			72		72
Net loss				(56,418)	(56,418)
Balances at Dec. 31, 2024		$ 1,141,060	$ 7	$ (965,522)	$ 175,545
Balance (in shares) at Dec. 31, 2024	49,471				49,471